Covington-based Bexion Pharmaceuticals is a big fan of Kentucky, in part because KY Innovation offers impactful startups the boost they need to pursue big goals.
In Bexion’s case, that’s innovative cancer therapeutics.
Bexion is developing BXQ-350, an oncology treatment that targets the cancer cell’s environment. The product has shown a strong safety and tolerability in early clinical trials and could be revolutionary for the way cancer is treated.
BXQ-350 is also being explored for treating…
